Latest developments at Biocell


Covid-19: Auckland firm develops RNA production platform, paving way for Kiwi vaccine

Stuff, Auckland, NZ, 06 Nov 2021

A Papatoetoe company has developed the ability to mass-produce a crucial ingredient in cutting edge pharmaceuticals, setting the stage for homegrown Covid-19 vaccines. Biotechnology firm BioCell has devised a way to produce ribonucleic acid (RNA) on an industrial scale never before seen in New Zealand. RNAs are molecules similar to DNA, crucial for the flow of genetic information […]

Video image
Biocell supplied RapidNA image

NZ-first vaccine filling machine nears completion, could boost vaccine supply

RNZ, Auckland, NZ, 13 August 2021

An Auckland-based biotechnology company says its New Zealand-first vaccine filling machine is on target for completion in Germany, and will potentially boost Covid-19 vaccine supply not only in New Zealand but globally […]

A vaccine filling machine (file image). Photo: Getty Images

Government allocates $3M to Biocell as part of the Covid-19 vaccine strategy., Wellington, NZ, 27 August 2020

Prime Minister Jacinda Ardern, and Research, Science and Innovation Minister Megan Wood have allocated $3 million to BioCell for the upgrade of our facilities, which will allow for large-scale[…]


Stabilitech takes next step in race for a vaccine, announces Biocell as manufacturer for OraPro-COVID-19

Burges Hill, UK, 12 June 2020

STABILITECH BIOPHARMA LTD (“Stabilitech”), a UK biotechnology company developing next generation vaccines and biopharmaceuticals, has announced today a partnership with BioCell […]

covid19 virus

Free Radical Scientist Awarded 2011 Rutherford Medal

Stuff, Auckland, NZ, 17 November 2011

The 2011 Rutherford Medal, New Zealand’s top science and technology honour, was awarded to Professor Christine Winterbourn, director of the free radical research group in the pathology department at the University of Otago […]